Human papillomavirus and prognosis of invasive cervical cancer: A population-based study

Journal of Clinical Oncology

Volumn 19, Issue 7, 2001, Pages 1906-1915

  Schwartz, S M ^a   Daling, J R ^a   Shera, K A ^a   Madeleine, M M ^a   McKnight, B ^a   Galloway, D A ^a   Porter, P L ^a   McDougall, J K ^a  

^a USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER INVASION; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MORTALITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SQUAMOUS CELL CARCINOMA; TREATMENT PLANNING; UTERINE CERVIX CARCINOMA; VIRUS TYPING; WART VIRUS;

EID: 0035300612     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.7.1906     Document Type: Article

References (51)

1. Cancer statistics, 2000
2. Cervical cancer
3. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
4. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective - International biological study on cervical cancer (IBSCC) Study Group
5. Possible prognostic significance of human papillomavirus type in cervical cancer
6. Rapid dysplastic transformation of human genital cells by human papillomavirus type 18
7. Differences in transformation activity between HPV-18 and HPV-16 map to the viral LCR-E6-E7 region
8. Human papillomavirus genotype as a prognostic indicator in carcinoma of the uterine cervix
9. Prognostic significance of polymerase chain reaction detected human papillomavirus of tumors and lymph nodes in surgically treated stage IB cervical cancer
10. Associations between oncogenic human papillomaviruses and local invasive patterns in cervical cancer
11. Human papillomavirus deoxyribonucleic acid as a prognostic indicator in early-stage cervical cancer: A possible role for type 18
12. Implications of human papillomavirus type for survival in cervical squamous cell carcinoma
13. Human papillomavirus type 18: Association with poor prognosis in early stage cervical cancer
14. Type of human papillomavirus is related to clinical features of cervical carcinoma
15. Human papillomavirus genotype as a major determinant of the course of cervical cancer
16. Favorable clinical outcome of cervical cancers infected with human papilloma virus type 58 and related types
17. Prognostic significance of the presence of human papillomavirus DNA in patients with invasive carcinoma of the cervix
18. Human papillomavirus types 16 and 18 in adenocarcinoma of the uterine cervix
19. Human papillomavirus and its prognostic significance in invasive carcinoma of the cervix in young patients
20. Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer
21. Human papilloma virus has no prognostic significance in cervical carcinoma
22. Detection and typing of human papillomavirus in cervical carcinomas in Russian women: A prognostic study
23. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection
24. The surveillance, epidemiology, and end results program: A national resource
25. Sample preparation from paraffin-embedded tissues
26. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses
27. Evidence of prevalent genital-type human papillomavirus infections in adults and children
28. Telomerase activation in cervical cancer
29. Genital human papillomavirus infection in female university students as determined by a PCR-based method
30. Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis
31. Proportional hazards tests and diagnostics based on weighted residuals
32. Adenocarcinoma of the uterine cervix
33. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States: A 24-year population-based study
34. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma
35. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
36. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer
37. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study
38. Identification of human papillomavirus types 16 and 18 deoxyribonucleic acid sequences in bulky cervical cancer after chemotherapy
39. HPV DNA presence and HPV genotypes as prognostic factors in low-stage squamous cell cervical cancer
40. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm
41. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias
42. Physical status and expression of HPV genes in cervical cancers
43. Association of human papillomavirus types 16 and 18 E6 proteins with p53
44. Human papillomavirus type 18 is associated with less apoptosis in fibroblast tumours than human papillomavirus type 16
45. Analysis of individual human papillomavirus types in cervical neoplasia: A possible role for type 18 in rapid progression
46. Evaluation of histologic, morphometric, and immunohistochemical criteria in the differential diagnosis of small cell carcinomas of the cervix with particular reference to human papillomavirus types 16 and 18
47. Human papillomavirus type 18 associates with more advanced cervical neoplasia than human papillomavirus type 16
48. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations
49. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia